Documentation

SILICA - FDA AI drugs draft guidance - comments

Accelerating innovation in rare diseases. Presentation of the recommendations of France Biotech's Rare Diseases Expert Group

The Inserm Guide to Good AI Practices (February 2025)

AI Governance in Practice Report 2024

White Paper : Artificial Health Data : Analysis and Areas for Consideration

GT AIS/F-CRIN - The evolution of clinical trial methodologies: new tools, new uses, and conditions for use (May 2025)